NCT06684418
- Conditions
- Artificial Intelligence (AI), Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Fudan university Shanghai Cancer Center Shanghai, China
Clinical trial condition
NSCLC (Non-small Cell Lung Cancer)
Explore clinical trials studying NSCLC (Non-small Cell Lung Cancer). Study availability and eligibility vary by location and protocol.
53 public trials
33 recruiting studies
NSCLC (Non-small Cell Lung Cancer) trial results
NCT06667167
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Shaare Zedek Medical Center Jerusalem, Israel
Recruiting
Cognitive Screening in Lung Cancer Patients
NCT06727370
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Istituto Europeo di Oncologia Milan, Italy
NCT07285434
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Biogenea Pharmaceuticals Ltd Thessaloniki, Macedonia, Greece
NCT07689812
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Advanced Solid Tumors Cancer, +54 more
- Locations
-
Not specified
Not Yet Recruiting
Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade
NCT07661966
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
- Locations
-
- Weill Cornell Medicine New York, United States
Not Yet Recruiting
A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation
NCT07668752
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Study of Sacituzumab Tirumotecan Combined With Toripalimab for Resectable Stage II-IIIB NSCLC
NCT07438600
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT07286942
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Jiangsu Cancer Hospital Nanjing, Jiangsu, China
Not Yet Recruiting
Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial
NCT07274384
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
Not specified